Cefuroxime - Revision history

Danbot: Remove disease-specific subsections now covered by AntibioticDose on disease pages (Pharyngitis, Sinusitis, Gonorrhea, Lyme, AOM)

2026-03-20T12:38:41Z

Remove disease-specific subsections now covered by AntibioticDose on disease pages (Pharyngitis, Sinusitis, Gonorrhea, Lyme, AOM)

@@ Línea 9: / Línea 9: @@
 ===Mild-Moderate Bacterial infections===
 *250-500mg PO BID x5-10 days
 ===Renal Dosing===
 *no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement
@@ Línea 40: / Línea 32: @@
 *3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food
 *>13 yo: Dose: 250-500mg tab PO BID x5-10 days; Info: dose, duration varies by infection type, severity
 ===Renal Dosing===
 *3 mo-12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement

Danbot: Fix corrupted content: restore correct Cefuroxime (2nd gen cephalosporin) content, was incorrectly showing Cefditoren

2026-03-20T12:13:23Z

Fix corrupted content: restore correct Cefuroxime (2nd gen cephalosporin) content, was incorrectly showing Cefditoren

Show changes

Danbot: Remove disease-specific entries now covered by AntibioticDose (4 sections)

2026-03-20T11:08:46Z

Remove disease-specific entries now covered by AntibioticDose (4 sections)

← Revisión anterior		Revisión del 11:08 20 mar 2026
Línea 7:		Línea 7:

	==Adult Dosing==		==Adult Dosing==
	~~===Chronic [[Bronchitis]], Acute bacterial exacerbation===~~
	*400 mg PO bid x10 days
	~~===[[Pharyngitis]]/Tonsillitis, streptococcal===~~
	*200mg PO bid x10 days
	===Skin infection===		===Skin infection===
	*200 mg PO bid x10 days		*200 mg PO bid x10 days
Línea 28:		Línea 24:

	==Pediatric Dosing==		==Pediatric Dosing==
	~~===12+ yo, [[Pharyngitis]]/Tonsillitis, streptococcal===~~
	*200mg PO bid x10 days
	~~===12+ yo, Skin infection===~~
	*200 mg PO bid x10 days

Danbot: Remove disease-specific dosing covered by dynamic SMW tables

2026-03-20T02:58:36Z

Remove disease-specific dosing covered by dynamic SMW tables

← Revisión anterior		Revisión del 02:58 20 mar 2026
Línea 9:		Línea 9:
	===Chronic [[Bronchitis]], Acute bacterial exacerbation===		===Chronic [[Bronchitis]], Acute bacterial exacerbation===
	*400 mg PO bid x10 days		*400 mg PO bid x10 days
	~~===[[Pneumonia]], community-acquired===~~
	*400 mg PO bid for at least 5 days
	**May D/C after five days if afebrile x48-72 hours
	===[[Pharyngitis]]/Tonsillitis, streptococcal===		===[[Pharyngitis]]/Tonsillitis, streptococcal===
	*200mg PO bid x10 days		*200mg PO bid x10 days
Línea 31:		Línea 28:

	==Pediatric Dosing==		==Pediatric Dosing==
	~~===12+ yo, Chronic [[Bronchitis]], Acute bacterial exacerbation===~~
	*400 mg PO bid x10 days
	~~===12+ yo, [[Pneumonia]], community-acquired===~~
	*400 mg PO bid x14 days
	===12+ yo, [[Pharyngitis]]/Tonsillitis, streptococcal===		===12+ yo, [[Pharyngitis]]/Tonsillitis, streptococcal===
	*200mg PO bid x10 days		*200mg PO bid x10 days

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:39:32Z

Restore original dosing content alongside dynamic SMW tables

Show changes

Danbot: Replace manual dosing with dynamic SMW tables

2026-03-20T01:54:42Z

Replace manual dosing with dynamic SMW tables

← Revisión anterior		Revisión del 01:54 20 mar 2026
Línea 7:		Línea 7:

	==Adult Dosing==		==Adult Dosing==
	===~~Mild-Moderate Bacterial infections~~===		===Indications by Disease===
	*250-500mg PO BID x5-10 days		{{#ask: [[Has DrugName::Cefuroxime]] [[Has Population::Adult]]
	~~===Steptococcal~~ [[~~Pharyngitis~~]]~~/Tonsillitis===~~		\|?Treats disease=Disease
	*250mg PO BID x10 days		\|?Has Dose=Dose
	~~===Acute~~ [[~~Sinusitis\|Maxillary Sinusitis]]===~~		\|?Has Context=Context
	*250mg PO BID x10 days; Info: ~~not recommended per IDSA guidelines~~		\|format=table
	~~===Uncomplicated [[Gonococcal~~]] ~~Infections===~~		\|limit=50
	*1000mg PO x1; Info: for infections of cervix, urethra, rectum; dual treatment for chlamydial co-infection recommended		\|mainlabel=-
	=~~==Early [[Lyme~~ Disease]]===		\|headers=show
	*500mg PO BID x20 days		\|sort=Treats disease
	==~~=Renal Dosing===~~		}}
	*no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement
	~~===Hepatic Dosing==~~=
	*not defined

	==Pediatric Dosing==		==Pediatric Dosing==
	===~~Mild-Moderate Bacterial Infections===~~		===Indications by Disease===
	*3 mo-12 yo: Dose: 30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food		{{#ask: [[Has DrugName::Cefuroxime]] [[Has Population::Pediatric]]
	*>13 yo: Dose: 250-500mg tab PO BID x5-10 days; Info: dose, duration varies by ~~infection type, severity~~		\|?Treats disease=Disease
	~~===[[Otitis Media (Peds)\|Acute Otitis Media]]~~===		\|?Has Dose=Dose
	*2 mo-5 yo Dose: ~~30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: give susp with food~~		\|?Has Context=Context
	*6-12 yo: Dose: 30mg/kg/day susp PO divided q12h x5-10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x5-10 days; Info: give susp with food		\|format=table
	~~===Acute Maxillary~~ [[~~Sinusitis]]===~~		\|limit=50
	*3 mo-12 yo: ~~Dose~~: ~~30mg/kg/day susp PO divided q12h x10 days; Max: 1000mg/day; Alt: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines; give susp with food~~		\|mainlabel=-
	*>13 yo: Dose: 250mg tab PO BID x10 days; Info: not recommended per IDSA guidelines		\|headers=show
	~~===Streptococcal [[Pharyngitis~~]]~~/Tonsillitis===~~		\|sort=Treats disease
	*3 mo-12 yo: Dose: 20mg/kg/day susp PO divided q12h x10 days; Max: 500mg/day; Info: give with food		}}
	*>13 yo: Dose: 250mg tab PO BID x10 days
	~~===Uncomplicated~~ [[~~Gonococcal]] Infections===~~
	*adolescents: ~~Dose: 1000mg tab PO x1; Info~~: ~~for infections of cervix, urethra, rectum; dual treatment for [[chlamydial~~]] ~~co-infection recommended~~
	=~~==Early [[Lyme~~ Disease]]===
	*>13 yo: Dose~~: 500mg tab PO BID x20 days~~
	===~~Renal Dosing==~~=
	*3 mo-~~12 yo: CrCl <10: 15mg/kg PO susp q24h; HD: give dose after dialysis, no supplement; PD: no supplement~~
	*>13 yo: renal impairment: no adjustment; HD: give dose after dialysis, no supplement; PD: no supplement

	~~===Hepatic Dosing==~~=
	*not defined

	==Special Populations==		==Special Populations==

Masoodrm: /* General */

2025-12-10T18:24:50Z

General

← Revisión anterior		Revisión del 18:24 10 dic 2025
Línea 4:		Línea 4:
	*Dosage Strength: tablet: 250mg, 500mg; powder for injection: 750mg, 1.5g, 7.5g, 75g, 225g		*Dosage Strength: tablet: 250mg, 500mg; powder for injection: 750mg, 1.5g, 7.5g, 75g, 225g
	*Routes of Administration: PO, IV, IM		*Routes of Administration: PO, IV, IM
	*Common Trade Names: Ceftin, Zinacef		*Common Trade Names: Ceftin, Zinacef, Kefurox

	==Adult Dosing==		==Adult Dosing==

Ostermayer at 16:09, 18 July 2025

2025-07-18T16:09:40Z

← Revisión anterior		Revisión del 16:09 18 jul 2025
Línea 1:		Línea 1:
	==General==		==General==
	*Type: 2nd generation [[Is DrugClass::cephalosporin]]		*Type: [[Is Generation::2nd generation]] [[Is DrugClass::cephalosporin]]
	*Dosage Forms: tablet, powder for injection		*Dosage Forms: tablet, powder for injection
	*Dosage Strength: tablet: 250mg, 500mg; powder for injection: 750mg, 1.5g, 7.5g, 75g, 225g		*Dosage Strength: tablet: 250mg, 500mg; powder for injection: 750mg, 1.5g, 7.5g, 75g, 225g

Ostermayer at 14:50, 18 July 2025

2025-07-18T14:50:07Z

← Revisión anterior		Revisión del 14:50 18 jul 2025
Línea 1:		Línea 1:
	==General==		==General==
	*Type: 2nd generation [[cephalosporin]]		*Type: 2nd generation [[Is DrugClass::cephalosporin]]
	*Dosage Forms: tablet, powder for injection		*Dosage Forms: tablet, powder for injection
	*Dosage Strength: tablet: 250mg, 500mg; powder for injection: 750mg, 1.5g, 7.5g, 75g, 225g		*Dosage Strength: tablet: 250mg, 500mg; powder for injection: 750mg, 1.5g, 7.5g, 75g, 225g

ClaireLewis: /* References */

2019-09-19T22:04:05Z

References

← Revisión anterior		Revisión del 22:04 19 sep 2019
Línea 225:		Línea 225:

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:ID]]